J&J beats forecasts as sales of new drugs shine

[riky]

J&J beats forecasts as sales of new drugs shine

<p><a href="http://news.yahoo.com/j-j-beats-forecasts-helped-medicines-120820282--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/KpLeyP.zYUh0QjiXyKRVKQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-04-15T122637Z_2_CBREA3E0XX400_RTROPTP_2_JOHNSONANDJOHNSON.JPG" width="130" height="86" alt="Products made by Johnson &amp; Johnson for sale on a store shelf in Westminster" align="left" title="Products made by Johnson &amp; Johnson for sale on a store shelf in Westminster" border="0" /></a>Johnson &amp; Johnson reported quarterly earnings well above expectations, as strong sales of new drugs offset weak demand for consumer products and medical devices, and the company slightly raised its full-year profit view. J&amp;J on Tuesday said it earned $4.73 billion, or $1.64 per share, in the first quarter. &quot;Strong pharmaceuticals results showcased a very strong 2014 start for J&amp;J,&quot; said Morningstar analyst Damien Conover, referring to sales growth of almost 11 percent for prescription medicines in the quarter. He cited particularly strong sales of immunology medicines and for the company's recently approved Olysio treatment for hepatitis C. The hepatitis drug, a protease inhibitor, was approved by U.S. regulators in November and captured global sales of $354 million in the first quarter.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login